Forskningsradar
← Life Sciences
Life Sciences 5.3 🇸🇪

Diabetes may worsen melanoma survival rates, study suggests

A new study published in the British Journal of Dermatology examines whether type 2 diabetes affects how melanoma patients respond to treatment and survive the disease. The finding could reshape how oncologists assess patient risk and tailor care plans for the growing population with both conditions.

Originaltitel: Type 2 diabetes in melanoma patients: a potential prognostic risk factor?

Generera ett redaktionellt utkast på svenska